Repurposed for Aging
2024
Repurposing FDA-Approved Drugs for Aging
publication
Author Information
Author(s): Aleksic Sandra
Hypothesis
Can repurposed FDA-approved drugs extend healthspan and lifespan in aging populations?
Conclusion
Repurposing FDA-approved drugs may provide a cost-effective strategy to extend healthspan and lifespan by targeting aging biology.
Supporting Evidence
- FDA-approved drugs can be repurposed to target aging biology.
- Metformin has shown lifespan extension in preclinical models.
- GLP1 receptor agonists and SGLT2 inhibitors have healthspan benefits beyond diabetes treatment.
Takeaway
Some medicines that are already approved for other uses might help people live healthier for longer as they age.
Methodology
The study discusses the potential of FDA-approved drugs as gerotherapeutics based on existing clinical evidence and preclinical models.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website